BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 748K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

Advanced Search

11 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Discovery of JAB-3312, a Potent SHP2 Allosteric Inhibitor for Cancer Treatment.EBI
Jacobio Pharmaceuticals
COMPOSITION AND METHOD FOR TREATMENT OF GRAM NEGATIVE BACTERIAL INFECTIONBDB
The State University of New York
Small molecule inhibitors of TEAD transcription factorsBDB
The General Hospital
NOVEL COMPOUNDS, COMPOSITIONS, AND THERAPEUTIC USES THEREOFBDB
Breakpoint Therapeutics
MACROCYCLE COMPLEMENT FACTOR B INHIBITORSBDB
Alexion Pharmaceuticals
PREPARATION AND APPLICATION METHOD OF HETEROCYCLIC COMPOUNDS AS KRAS INHIBITORBDB
Shanghai Kechow Pharma
2-beta-naphthyl-acetic acid analogs as AKR1C3 inhibitors and methods of using sameBDB
The Trustees of The University of Pennsylvania
Substituted pyrazoles as LRRK2 inhibitorsBDB
Oscotec
Heteroaryl Rheb inhibitors and uses thereofBDB
Navitor Pharmaceuticals
Pyridinone derivatives and their use as selective ALK-2 inhibitorsBDB
Novartis
Serine/threonine kinase inhibitorsBDB
Genentech